Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 781 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Mineralys Therapeutics, Inc.
Market Cap
$1.98B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$1.98B
Gross Margin
86.13%
TTM Avg
85.03%
3Y Avg
84.60%
5Y Avg
84.81%
Market Cap
$2.02B
Gross Margin
90.36%
TTM Avg
88.22%
3Y Avg
91.04%
5Y Avg
93.63%
Market Cap
$2.04B
Gross Margin
97.82%
TTM Avg
97.53%
3Y Avg
97.80%
5Y Avg
96.20%
Market Cap
$1.91B
Gross Margin
70.49%
TTM Avg
67.64%
3Y Avg
66.50%
5Y Avg
65.90%
Market Cap
$2.05B
Gross Margin
17.11%
TTM Avg
17.72%
3Y Avg
20.44%
5Y Avg
20.08%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | $1.98B | 0.00% | 0.00% | 0.00% | N/A |
| Inspire Medical Systems, Inc. (INSP)vs › | $1.98B | 86.13% | 85.03% | 84.60% | 84.81% |
| AxoGen, Inc. (AXGN)vs › | $1.96B | 74.56% | 75.05% | 76.31% | 78.00% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 90.36% | 88.22% | 91.04% | 93.63% |
| Progyny, Inc. (PGNY)vs › | $2.04B | 24.57% | 22.67% | 22.13% | 21.88% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.04B | 97.82% | 97.53% | 97.80% | 96.20% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.91B | 70.49% | 67.64% | 66.50% | 65.90% |
| Alvotech (ALVO)vs › | $2.05B | 60.45% | 60.99% | 17.21% | 44.81% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.05B | 17.11% | 17.72% | 20.44% | 20.08% |
| Immunome, Inc. (IMNM)vs › | $1.90B | 57.43% | 78.72% | 64.36% | 42.91% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
